Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Colman

Showing results (401-410 of 466) with videos related to

Pageof 47
Sort By:
Blood|August 1, 1979
Thromboxane synthesis and platelet protein release during simulated extracorporeal circulationV P Addonizio, J B Smith, L R Guiod, et al.
Proceedings of the Association of American Physicians|January 1, 1997
Activation of the kallikrein-kinin system in arthritis and enterocolitis in genetically susceptible rats: modulation by a selective plasma kallikrein inhibitorR W Colman, A Stadnicki, C A Kettner, et al.
Nature|December 13, 1979
Thrombosis and haemostasisR W Colman, G Stewart, A Budzynski, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|May 8, 2001
Bradykinin receptor antagonists type 2 attenuate the inflammatory changes in peptidoglycan-induced acute arthritis in the Lewis ratA B Uknis, R A DeLa Cadena, R Janardham, et al.
Advances in Experimental Medicine and Biology|January 1, 1983
Role of high molecular weight kininogen in modulating the inactivation of human plasma kallikrein by plasma protease inhibitorsM Schapira, A James, C F Scott, et al.
The Journal of Biological Chemistry|July 5, 1985
Two mechanisms for inhibition of ADP-induced platelet shape change by 5'-p-fluorosulfonylbenzoyladenosine. Conversion to adenosine, and covalent modification at an ADP binding site distinct from that which inhibits adenylate cyclaseD C Mills, W R Figures, L M Scearce, et al.
Journal of Thrombosis and Haemostasis : JTH|October 31, 2009
Cleaved high molecular weight kininogen inhibits tube formation of endothelial progenitor cells via suppression of matrix metalloproteinase 2Y Wu, J Dai, N G Schmuckler, et al.
Blood|August 15, 1997
Human kininogens regulate thrombin binding to platelets through the glycoprotein Ib-IX-V complexH N Bradford, R A Dela Cadena, S P Kunapuli, et al.
The Journal of Biological Chemistry|May 31, 1996
Mapping of the discontinuous kininogen binding site of prekallikrein. A distal binding segment is located in the heavy chain domain A4H Herwald, T Renné, J C Meijers, et al.
The Annals of Thoracic Surgery|September 4, 1999
Aprotinin inhibits thrombin formation and monocyte tissue factor in simulated cardiopulmonary bypassM M Khan, N Gikakis, S Miyamoto, et al.
Pageof 47

Showing results (401-410 of 466) with videos related to

Sort By:
Pageof 47
Blood|August 1, 1979
Thromboxane synthesis and platelet protein release during simulated extracorporeal circulationV P Addonizio, J B Smith, L R Guiod, et al.
Proceedings of the Association of American Physicians|January 1, 1997
Activation of the kallikrein-kinin system in arthritis and enterocolitis in genetically susceptible rats: modulation by a selective plasma kallikrein inhibitorR W Colman, A Stadnicki, C A Kettner, et al.
Nature|December 13, 1979
Thrombosis and haemostasisR W Colman, G Stewart, A Budzynski, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|May 8, 2001
Bradykinin receptor antagonists type 2 attenuate the inflammatory changes in peptidoglycan-induced acute arthritis in the Lewis ratA B Uknis, R A DeLa Cadena, R Janardham, et al.
Advances in Experimental Medicine and Biology|January 1, 1983
Role of high molecular weight kininogen in modulating the inactivation of human plasma kallikrein by plasma protease inhibitorsM Schapira, A James, C F Scott, et al.
The Journal of Biological Chemistry|July 5, 1985
Two mechanisms for inhibition of ADP-induced platelet shape change by 5'-p-fluorosulfonylbenzoyladenosine. Conversion to adenosine, and covalent modification at an ADP binding site distinct from that which inhibits adenylate cyclaseD C Mills, W R Figures, L M Scearce, et al.
Journal of Thrombosis and Haemostasis : JTH|October 31, 2009
Cleaved high molecular weight kininogen inhibits tube formation of endothelial progenitor cells via suppression of matrix metalloproteinase 2Y Wu, J Dai, N G Schmuckler, et al.
Blood|August 15, 1997
Human kininogens regulate thrombin binding to platelets through the glycoprotein Ib-IX-V complexH N Bradford, R A Dela Cadena, S P Kunapuli, et al.
The Journal of Biological Chemistry|May 31, 1996
Mapping of the discontinuous kininogen binding site of prekallikrein. A distal binding segment is located in the heavy chain domain A4H Herwald, T Renné, J C Meijers, et al.
The Annals of Thoracic Surgery|September 4, 1999
Aprotinin inhibits thrombin formation and monocyte tissue factor in simulated cardiopulmonary bypassM M Khan, N Gikakis, S Miyamoto, et al.
Pageof 47